[Clinical benefits of montelukast sodium treatment in chronic adult asthma].
This paper presents the resulţs of Montelukast sodic therapy in 16 asthmatic patients, in a prospective study. Montelukast sodic was given in severe chronic asthma treated by inhaled or systemic steroids before. Patients were followed up for three months regarding: clinical symptoms, respiratory function (FEV), blood and sputum eozinophyls. Short term therapy showed a great improvement in day and night symptoms, a reduction of sputum and blood eozinophyls and an increased FEV. Long term therapy could be protective for asthma exacerbations and will provide constant good life quality of asthmatics.
Trofor
Antigona
A
Facultatea de Medicină Stomatologică Clinica de Pneumologie, Universitatea de Medicină şi Farmacie Gr.T. Popa Iaşi.
Rascarachi
Gabriela
G
Popa
Elena
E
Chiseliţă
Irina
I
D000085:Acetates / Q000627:therapeutic use*; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D003196:Computer Graphics; D003521:Cyclopropanes; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D011804:Quinolines / Q000627:therapeutic use*; D012383:Romania; D013440:Sulfides; D011795:Surveys and Questionnaires
D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D011804:Quinolines; D013440:Sulfides; C093875:montelukast